CHRONIC HEPATITIS B
Clinical trials for CHRONIC HEPATITIS B explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS B trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hepatitis b moms: drug may shield babies from infection
Disease control Recruiting nowThis study tests the drug TAF in 50 pregnant women with chronic hepatitis B to see if it safely reduces the virus and prevents passing it to their babies. Women take one tablet daily from week 28-32 of pregnancy until delivery. Researchers will measure drug levels in blood and br…
Matched conditions: CHRONIC HEPATITIS B
Phase: PHASE4 • Sponsor: First People's Hospital of Hangzhou • Aim: Disease control
Last updated Jun 22, 2026 11:57 UTC
-
Diabetes drug may shield hepatitis b patients from liver failure
Disease control Recruiting nowThis 5-year study tests whether dapagliflozin, a diabetes drug, can prevent serious liver complications in people with chronic hepatitis B and diabetes who already have early liver scarring. 412 participants will receive either dapagliflozin or a placebo daily. The goal is to see…
Matched conditions: CHRONIC HEPATITIS B
Phase: PHASE4 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 22, 2026 11:55 UTC